About St Mary's Hosp (Univ of Rochester/Infectious Diseases)
Clinical Trials at St Mary's Hosp (Univ of Rochester/Infectious Diseases)
During the past decade, St Mary's Hosp (Univ of Rochester/Infectious Diseases) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "St Mary's Hosp (Univ of Rochester/Infectious Diseases)"
#1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "Washington University School of Medicine" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at St Mary's Hosp (Univ of Rochester/Infectious Diseases)
According to Clinical.Site data, the most researched conditions in "St Mary's Hosp (Univ of Rochester/Infectious Diseases)" are
"HIV Infections" (8 trials), "Candidiasis, Oral" (1 trials), "Lipodystrophy" (1 trials), "Lymphoma, AIDS-Related" (1 trials) and "Lymphoma, Non-Hodgkin" (1 trials). Many other conditions were trialed in "St Mary's Hosp (Univ of Rochester/Infectious Diseases)" in a lesser frequency.
Clinical Trials Intervention Types at St Mary's Hosp (Univ of Rochester/Infectious Diseases)
Most popular intervention types in "St Mary's Hosp (Univ of Rochester/Infectious Diseases)" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Nelfinavir mesylate" (3 trials), "Didanosine" (2 trials), "Efavirenz" (2 trials), "Indinavir sulfate" (2 trials) and "Lamivudine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at St Mary's Hosp (Univ of Rochester/Infectious Diseases)
The vast majority of trials in "St Mary's Hosp (Univ of Rochester/Infectious Diseases)" are
7 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at St Mary's Hosp (Univ of Rochester/Infectious Diseases)
Currently, there are NaN active trials in "St Mary's Hosp (Univ of Rochester/Infectious Diseases)".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in St Mary's Hosp (Univ of Rochester/Infectious Diseases),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in St Mary's Hosp (Univ of Rochester/Infectious Diseases), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 3 trials that are defined as “Not Applicable".